잠시만 기다려 주세요. 로딩중입니다.

악성종양에 대한 Bleomycin 사용 경험예

Bleomycin used for Esophageal and Lung Carcinoma

대한흉부외과학회지 1970년 3권 2호 p.143 ~ 147
박성진, 김진영, 이근호,
소속 상세정보
박성진 (  ) - 가톨릭대학교 의과대학 부속성모병원 정형외과학교실
김진영 (  ) - 가톨릭대학교 의과대학 부속성모병원 정형외과학교실
이근호 (  ) - 가톨릭대학교 의과대학 부속성모병원 정형외과학교실

Abstract


Bleomycin is known as a antibiotic agent for malignant tumors especially sguamous cell carcinoma.
We have treated 2 cases of malignant tumors, each one esophageal and lung carcinoma with bleomycin, 630 mg and 510 mg respectively.
In case of esophageal carcinoma, the subjective symptoms such as dysphagea and swallowing disturbance are temporally relieved, but the irregular filling defect is not significantly changed in esophagogram.
In case of lung carcinoma, the atelectasis of right upper lobe on chest X-ray was slightly regressed in its size without effective improvement of subjective symptoms. However, following additional radioactive ^(60)Co irradiation therapy (5200r), marked regression of tumor density and aeration of right upper lobe was observed. But 2 weeks later of ceasation of irradiation, atelectasis of right upper lobe was again developed.
Fever, anorexia, headache and eruption were developed during the treatmeat with bleomycin in both cases but the sign or symptoms of bone marrow depression, renal or liver damage were not noted.

키워드

원문 및 링크아웃 정보

  

등재저널 정보

KCI
KoreaMed
KAMS